Tonix Pharmaceuticals Holding Corp. (TNXP)

Latest News

View all news

May 21, 2025

Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction

May 14, 2025

Tonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations

May 12, 2025

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

View all news

TNX-1700 for Gastric and Colorectal Cancers

View Presentation

Annual Meeting of Shareholders

View Event View All Events

Latest Financial Results

Q1 2025

Quarter Ended Mar 31, 2025

Earnings Release

10-Q

PDF HTML

XBRL

ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2024

IR Contacts

Company

Tonix Pharmaceuticals Holding Corp.
26 Main Street
Suite 101
Chatham, NJ 07928
T: 862-799-8599
investor.relations@tonixpharma.com

Investor Relations

TONIX Pharmaceuticals
investor.relations@tonixpharma.com

Transfer Agent

VStock Transfer, LLC
77 Spruce Street
Suite 201
Cedarhurst, NY 11516
T: 212-828-8436
https://www.vstocktransfer.com

Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.